Toggle Offcanvas
...
 
Epoetin Tenders

Epoetin Tenders

View Epoetin tenders, RFPs and contracts. Bid on readily available Epoetin tenders with the best and most comprehensive tendering platform, since 2002.
Epoetin is a synthetic form of erythropoietin, a hormone that stimulates red blood cell production. It is used to treat anemia in patients with chronic kidney disease or undergoing chemotherapy to reduce the need for blood transfusions.

Bidding for Epoetin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Epoetin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Epoetin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Epoetin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

136 Live Notices for Epoetin Tenders

Showing 1 to 20

Supply of Medicine and Medical / Surgical equipments : Item Code No. 100108F99\nErythropoietin, Epoetin Alfa Injection\n4000IU/1ml Vial\nPack Size – 1 Vial etc .
country Sri Lanka
posting date12 Jul 2025
deadline20 Aug 2025
Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Epoetin Zeta
country Germany
posting date20 May 2025
deadline10 May 2027
Completion Of Non-Exclusive Discount Agreements According To § 130 A (8) Sgb V With The Active Ingredient Epoetin Zeta
country Germany
posting date20 May 2025
deadline10 May 2027
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
country Germany
posting date15 May 2025
deadline31 Dec 2026
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028
Completion Of A Non -Exclusive Discount Agreement According To Section 130A (8) Sgb V On The Active Ingredient Erythropoietin, Atc B03Xa01 For The Period 01.06.2025 - 31.05.2027 (Plus Extension Option 1X12 Months)
country Germany
posting date17 Apr 2025
deadline05 Apr 2028

Share Share this page